Investing
LaFleur Minerals
Investor Insight With a strategic asset base in the prolific Abitibi Gold Belt near Val d’Or, and a fully permitted...
Read more
Skyharbour Resources
Investor Insight In the current strong market dynamic for uranium, Skyharbour Resources is a compelling investment opportunity driven by its...
Read more
Brunswick Exploration Announces AGM Results
Brunswick Exploration Inc. (“BRW” or the “Corporation”) is pleased to announce the results of its annual general meeting (“AGM”) of...
Read more
Grande Portage Closes Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
Grande Portage Resources Ltd. (TSXV:GPG)(OTCQB:GPTRF)(FSE:GPB) (‘Grande Portage‘ or the ‘Company‘) is pleased to announce that it has closed its non-brokered...
Read more
Blue Sky Hosts Community and Stakeholder Water Sampling Event at the Ivana Uranium-Vanadium Project, Argentina
Blue Sky Uranium Corp. (TSX-V: BSK, FSE: MAL2; OTC: BKUCF), (‘Blue Sky’ or the ‘Company’) is pleased to announce that...
Read more
Blue Sky Uranium Closes 1st Tranche & Increases Oversubscribed Non-Brokered Private Placement
Blue Sky Uranium Corp. (TSX-V: BSK, FSE: MAL2; OTC: BKUCF), (‘Blue Sky’ or the ‘Company’) announces that due to high...
Read more
GMV Minerals Inc. Extends Exclusive Option to Acquire Mexican Hat Mining Claims – Commissions Updated Preliminary Economic Assessment
GMV Minerals Inc. (the ‘Company’ or ‘GMV’) (TSXV:GMV)(OTCQB:GMVMF) announces that it has elected to extend its exclusive initial five (5)...
Read more
Aston Bay and American West Metals Announce Drilling Preparations Underway at the Storm Project, Nunavut, Canada
Camp opening and logistics have commenced with geophysics and drilling to follow in the coming weeks Aston Bay Holdings Ltd....
Read more
Osisko Metals Intersects 0.33% Cu Over 258 Metres at Gaspé
Includes 15.6 Metres Averaging 1.47% Cu and 8.5 g/t Ag E Zone Skarn Returns 29.7 Metres Averaging 1.92% Cu and...
Read more
Radiopharm Theranostics Granted U.S. Food and Drug Administration Fast Track Designation for RAD101 Imaging in Brain Metastases
Radiopharm Theranostics (ASX:RAD, ‘Radiopharm’ or the ‘Company’), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of...
Read more
